Auszug
Die intrazerebrale Blutung (ICB) ist nach dem ischämischen Infarkt die zweithäufigste Schlaganfallursache. Die Prognose ist bei der Mehrheit der Patienten ungünstig. Etwa 50% der Patienten stirbt an den Folgen der Blutung, meist innerhalb der ersten 30 Tage. Die überlebenden Patienten sind häufig schwer behindert. Nur ca. 20% der Patienten sind nach 6 Monaten unabhängig. Im Vergleich zu Patienten mit schweren ischämischen Schlaganfällen ist aber auch nach einer großen ICB eine unerwartet gute Erholung möglich.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Andersen CS for the INTERACT Investigators (2008) Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol 7:391–399
Auer LM, Deinsberger W, Niederkorn K, Gell G, Kleinert R, Schneider G, Holzer P, Bone G, Mokry M, Korner E, et al. (1989) Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma: a randomized study. J Neurosurg 70:530–535
Batjer HH, Reisch JS, Allen BC, Plaizier LJ, Su CJ (1990) Failure of surgery to improve outcome in hypertensive putaminal hemorrhage. A prospective randomized trial. Arch Neurol 47:1103–1106
Broderick JP, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D, Mayberg M, Morgenstern L, Ogilvy CS, Vespa P, Zuccarello M (2007) Guidelines for the management of spontaneous intracerebral hemorrhage in adults. 2007 update. Stroke 38:2001–2023
Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L, Spilker J, Duldner J, Khoury J (1997) Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 28:1–5
Chen X, Yang H, Czherig Z (1992) A prospective randomised trial of surgical and conservative treatment of hypertensive intracranial haemorrhage. Acta Acad Med Shanghai 19:237–240
Coon WW, Willis PW (1974) Hemorrhagic complications of anticoagulant therapy. Arch Intern Med 133:386–392
Davis SM, Broderick J, Hennerici M, Brun NC, Diringer MN, Mayer SA, Regtrup K, Steiner T (2006) Hematoma growth is determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 66:1175–1181
Diringer MN, Skolnick BE, Mayer SA, Steiner T, Davis SM, Brun NC, Broderick JP (2008) Risk of thromboembolic events in controlled trials of rFVIIa in spontaneous intracerebral hemorrhage. Stroke 39:850–856
Flaherty ML, Haverbusch M, Sekar P, Kissela B, Kleindorfer D, Moomaw CJ, Sauerbeck L, Schneider A, Broderick JP, Woo D (2006) Long-term mortality after intracerebral hemorrhage. Neurology 66:1182–1186
Fogelholm R; Murros K, Rissanen A, Avikainen S (2005) Admission blood glucose and short term survival in primary intracerebral haemorrhage. A population based study. J Neurol Neurosurg Psychiatry 76:349–353
Goldstein JN, Fazen LE, Snider R, Schwab K, Greenberg SM, Smith EE, Lev MH, Rosand J (2007) Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage. Neurology 68:889–894
Hankey GJ, Hon C (1997) Surgery for primary intracerebral hemorrhage: is it safe and effective? A systematic review of case series and randomized trials. Stroke 28:2126–2132
Hanley D for the CLEAR IVH Investigative Team (2007) Results of CLEAR IVH B: Dose-response for 3rd and 4th ventricular blood clearance. Cerebrovasc Dis 23:54 (abstract)
Huttner HB, Schellinger PD, Hartmann M, Köhrmann M, Juettler E, Wikner J, Mueller S, Meyding-Lamade U, Strobl R, Mansmann U, Schwab S, Steiner T (2006) Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy. Stroke 37:1465–1470
Juvela S, Heiskanen O, Poranen A, Valtonen S, Kuurne T, Kaste M, Troupp H (1989) The treatment of spontaneous intracerebral hemorrhage. A prospective randomized trial of surgical and conservative treatment. J Neurosurg 70:755–758
Kase CS, Caplan LR, Hrsg. (1994) Intracerebral Hemorrhage. Butterworth-Heinemann, Boston London Oxford
Kirollos RW, Tyagi AK, Ross SA, van Hille PT, Marks PV (2001) Management of spontaneous cerebellar hematomas: a prospective treatment protocol. Neurosurgery 49:1378–1386
Lacut K, Bressollette L, Le Gal G, Etienne E, De Tinteniac A, Renault A, Rouhart F, Besson G, Garia JF, Mottier D, Oger E. Prevention of venous thrombosis in patients with acute intracerebral hemorrhage. Neurology 65:865–869
Lee SB, Manno EM, Layton KF, Wijdicks EFM (2006) Progression of warfarin-associated intracerebral hemorrhage after INR normalization with FFP. Neurology 67:1272–1274
Little JR, Tubman DE, Ethier R (1978) Cerebellar hemorrhage in adults. Diagnosis by computerized tomography. J Neurosurg 48:575–579
Lovelock C, Molyneux A, Rothwell P; on behalf of the Oxford Vascular Study (2007) Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study. Lancet Neurol 6:487–493
Masdeu, JC, Irimia P, Asenbaum S, Bogousslavsky J, Brainin M, Chabriat H, Herholz K, Markus HS, Martínez-Vila E, Niederkorn K, Schellinger PD, Seitz RJ ((2006) EEFNS guideline on neuroimaging in acute stroke. Report of an EFNS task force. Eur J Neurol 13:1271–1283
Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T (2005) Recombinant activated factor VII for acute intracerebral intracerebral hemorrhage. N Engl J Med 352;777–785
Mayer SA for the FAST Trial Investigative Team (2008) Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 358:2127–2137
McKissock W, Richardson A, Taylor J (1961) Primary intracerebral haemorrhage: a controlled trial of surgical and conservative treatment in 180 unselected cases. Lancet 2:221–226
Mendelow AD, Gregson BA, Fernandes HM, Murray GD, Teasdale GM, Hope DT, Karimi A, Shaw MDM, Barer DH (2005) Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the international surgical trial in intracerebral haemorrhage (STICH): a randomised trial. Lancet 365:387–389
Misra UK, Kalita J, Ranjan P, Mandal SK (2005) Mannitol in intracerebral hemorrhage. A randomized controlled study. J Neurol Sci 234:41–45
Morgenstern LB, Frankowski RF, Shedden P, Pasteur W, Grotta JC (1998) Surgical treatment for intracerebral hemorrhage (STICH): a single-center, randomized clinical trial. Neurology 51:1359–1363
Naff NJ, Hanley DF; Keyl PM, Tuhrim S, Kraut M, Bederson J, Bullock R, Mayer SA, Schmutzhard E (2004) Intraventricular thrombolysis speeds clot resolution: Results of a pilot prospective, randomized, double-blind controlled trial. Neurosurgery 54:577–581
Nilsson OG, Polito A, Saveland H, Ungerstedt U, Norstrom CH (2006) Are primary supratentorial hemorrhages surrounded by a biochemical penumbra? A microdialysis study. Neurosurgery 59:521–528
Passero S, Rochi R, Rossi S, Ulivelli M, Vatti G (2002) Seizures after spontaneous intracerebral hemorrhage. Epilepsia 43:1175–1180
Poungvarin N, Bhoopat W, Viriyavejakul A, Rodprasert P, Buranasiri P, Sukondhabhant S, Hensley M, Strom BL (1987) Effects of dexamethasone in primary supratentorial intracerebral hemorrhage. N Engl J Med 316:1229–1233
Rubinstein AA, Wijdicks EFM (2007) Determinants of outcome in anticoagulation-associated cerebral hematoma requiring emergency evacuation. Arch Neurol 64:203–206
Saloheimo P, Ahonen M, Juvela S, Pythinen J, Savolainen E-R, Hillbom M (2006) Regular Aspirin-use preceding the onset of primary intracerebral hemorrhage is an independent factor for death. Stroke 37:129–133
Smith EE, Greenberg SM (2003) Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Curr Atheroscler Rep 5:260–26
Sorimachi T, Juji Y, Morita K, Tanaka R (2007) Predictors of hematoma enlargement in patients with intracerebral hemorrhage treated with rapid administration of antifibrinolytic agents and strict blood pressure control. J Neurosurg 106;250–254
Teernstra OPM, Evers SMA, Lodder J, Leffers P, Franke CL, Blaauw G (2003) Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator. A multicenter randomized controlled trial (SIPCHA). Stroke 34:968–974
Vespa P, McArthur D, Miller C, O’Phelan K, Frazee, J, Kidwell C, Saver J, Starkman S, Martin N (2005) Frameless stereotactic aspiration and thrombolysis of deep intracerebral hemorrhage is associated with reduction of hemorrhage volume and neurological improvement. Neurocritical Care 2:274–281
Wagner KR (2007) Modeling intracerebral hemorrhage. Glutamate, nuclear factor-kB signaling and cytokines. Stroke 38:753–758
Zazulia AR, Diringer MN, Videen TO, Adams RE, Yundt K, Aiyagari V, Grubb RL, Powers WJ (2001) J Cereb Blood Flow Metab 21:804–810
Zuccarello M, Brott T, Derex L, Kothari R, Sauerbeck L, Tew J, Van Loveren H, Yeh HS, Tomsick T, Pancioli A, Khoury J, Broderick J (1999) Early surgical treatment for supratentorial intracerebral hemorrhage: a randomized feasibility study. Stroke 30:1833–1839
Literatur
Ahmad I, Imaizumi S, Shimizu H (1996) Development of Calcitonin Gene-Related Peptide Slow-Release Tablet implanted in CSF Space for Prevention of cerebral vasospasm after experimental subarachnoid hemorrhage. Acta Neurochir 138: 1230–1240
Ayala C, Croft JB, Greenlund KJ (2002) Sex differences in US mortality rates for stroke and stroke subtypes by race/ethnicity and age, 1995–1998. Stroke 33: 1197–1201
Bailes JE, Spetzler RF, Hadley MN (1990) Management morbidity and mortality of poor-grade aneurysm patients. J Neurosurg 72: 559–566
Barker FG, Ogilvy S (1996) Efficacy of prophylactic Nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: A metaanalysis. J Neurosurg 84: 405–414
Elliott JP, Newell DW, Can DJ (1998) Comparison of ballon angioplasty and papaverin infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 88: 277–284
Feigin V, Anderson N, Rinkel G, et al (2005) Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage. Cochrane Database Syst Rev: CD004583
Fuse A, Rodesch G, Alvarez H (2000) Endovascular management of intradural berry aneurysms. Review of 203 consecutive patients managed between 1993 and 1998. Morphological and clinical results at mid-term follow-up. Intervent Neurorad 6: 27–40
Grond-Ginsbach C, Schnippering H, Steiner HH, Brandt T (2002) Ultrastructural connective tissue aberrations in patients with intracranial aneurysms. Stroke 33: 2192–2196
Gruber A, Ungersbock K, Reinprecht A, et al. (1998) Evaluation of cerebral vasospasm after early surgical and endovascular treatment of ruptured intracranial aneurysms. Neurosurgery 42:258–267
Haley EC, Kassell NF, Torner JV (1992) The international Cooperative Study on the timing of Aneurysm Surgery. The North American Experience. Stroke 23: 205–214
Haley EC, Kassell NF, Apperson-Hansen C, et al. (1997) A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurismal subarachnoid hemorrhage: a cooperative study in North America. J Neurosurg 86:467–474
Hunt WE, Hess RM (1968) Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 28: 14–20
Huttner, HB, Nagel S, Tognoni E, Köhrmann M, Jüttler E, Schellinger PD, Schwab S, Bardutzky J (2007) Lumbar drainage for communicating hydrocephalus in ICH patients with severe ventricular hemorrhage. Stroke 38: 183–187
Huttner HB, Hartmann M, Kohrmann M, Neher M, Stippich C, Hahnel S, Kress B. (2006) Repeated digital substraction angiography after perimesencephalic subarachnoid hemorrhage? J Neuroradiol. 33:87–89
Inagawa T (2002) Seasonal variation in the incidence of anuerysmal subarachnoid hemorrhage in hospital-and community-based studies. J Neurosurg 96: 497–509
International Study of unruptured intracranial aneurysms Investigators (1998) Unruptured intracranial aneurysms — risk of rupture and risks of surgical intervention. N Engl J Med 339: 1725–1733
Juvela S, Porras M, Poussa K (2000) Natural history of unruptured intracranial aneurysms: probability of and risk factors for aneurysm rupture. J Neurosurg 93: 379–387
Kassell NF, Haley EC jr, Apperson-Hansen C (1996) Randomized, double-blind, vehicle-controlled trial of Tirilazad mesylate in patients with aneurysmal subarachnoid hemorhage: A cooperative study in Europe, Australia, and New Zealand. J Neurosurg 84: 221–228
Kassell NF, Torner JC, Haley EC, Jane JA (1990) The international cooperative study on the timing of aneurysm surgery, part 1 and part 2. J Neurosurg 73: 18–47
Kim SJ, Choi IS (2000) Midterm outcome of partially thrombosed intracranial aneurysms treated with guglielmi detachable coils. Intervent Neurorad 6: 13–26
Kissela BM, Sauerbeck L, Woo D, Khoury J, Carrozzella J, Pancioli A (2002) Subarachnoid hemorrhage: A preventable disease with a heritable component. Stroke 33: 1321–1326
Klimo P Jr, Kestle JR, MacDonald JD, Schmidt RH (2004) Marked reduction of cerebral vasospasm with lumbar drainage of cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg 100:215–24
Laidlow JD, Siu KH (2002) Ultra-early surgery for aneurysmal subarachnoid hemorrhage outcomes for a consecutive series of 391 patients not selected in grade or age. J Neurosurg 97: 250–258
Lysakowski C, Walder B, Costanza MC, et al. (2001) Transcranial Doppler versus angiography in patients with vasospasm due to a ruptured cerebral aneurysm: A systematic review. Stroke 32:2292–2298.
Mayer SA, Kreiter KT, Copeland D, Bernardini GL, Bates JE, Peery S, Claassen J, Du YE, Connolly ES (2002) Global and domain-specific cognitive impairment and outcome after subarachnoid hemorrhage. Neurology 59: 1750–1758
Molyneux A, Kerr R, Stratton I (2002) International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a radnomized trial. Lancet 360: 1267–1274
Molyneux AJ, Kerr RS, Yu LM, Clarke M, Sneade M, Yarnold JA, Sandercock P, International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group (2005) International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet 366: 809–817
Mori T, Katayama Y, Kawamata T (1999) Improved efficiency of hypervolemic therapy with inhibition of natriuresis by fludrocortisone in patients with aneurismal subarachnoid hemorrhage. J Neurosurg 91: 947–952
Murayama Y, Nien YL, Duckwiler G, Gobin YP, Jahan R, Frazee J (2003) Guglielmi detachable coil embolization of cerebral aneurysms: 11 years’ experience. J Neurosurg 98: 959–966
Pelz DM (2003) Advances in interventional neuroradiology. Stroke 34: 357–358
Peerdeman SM, van Tulder MW, et al. (2003) Cerebral microdialysis as a monitoring method in subarachnoid hemorrhage patients, and correlation with clinical events—a systematic review. J Neurol 250:797–805.
Poeck K, Hacke W (2001) Neurologie, 11. Auflage Springer Berlin Heidelberg New York Tokyo, 274
Polin RS, Hansen CA, German P (1998) Intra-arterially administered papaverine for the treatment of symptomatic cerebral vasospasm. Neurosurgery 42: 1256–1264
Raftopoulos C, Mathurin P, Boscherini D (2000) Prospective analysis of aneurysm treatment in a series of 103 consecutive patients when endovascular treatment is considered the first option. J Neurosurg 93: 175–182
Sakowitz OW, Unterberg AW (2006) Detecting and treating microvascular ischemia after subarachnoid hemorrhage. Curr Opin Crit Care 12:103–11
Sarrafzadeh AS, Sakowitz OW, Kiening KL, Benndorf G, Lanksch W, Unterberg AW (2002) Bedside microdialysis: a tool to monitor cerebral metabolism subarachnoid hemorrhage patients? Crit Care Med 30: 1062–1070
Schievink WI (1997) Intracranial aneurysms. N Engl J Med 336: 28–40
Seifert V, Loeffler BM, Zimmermann M (1995) Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 82: 55–61
Steiner HH, Ranaie G, Jansen O (2000) Evaluation of complication rate after early surgical and endovascular treatment of ruptured intracarnial aneurysms (abstract). Zentralbl Neurochir 61Suppl 1: 19–20
Steiner HH, Unterberg A (1999) Die akute Subarachnoidalblutung. In: Neurologische Intensivmedizin, Schwab S, Krieger D, Hacke W (Hrsg), Springer Verlag Berlin-Heidelberg-New York, S 404–421
Teasdale GM, Drake CG, Hunt W, Kassell N, Sano K, Pertuiset B, De Villiers JC (1988) A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. J Neurol Neurosurg Psychiatry 51: 1457
Thomas JE, Rosenwasser RH, Armonda RA (1999) Safety of intrathecal sodium nitruprusside for the treatment and prevention of refractory cerebral vasospasm and ischemia in humans. Stroke 30: 1409–1416
Tseng MY, Czosnyka M, Richards H, et al (2005) Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke 36:1627–1632.
Tsutumi K, Ueki K, Usui M (1998) Risk of recurrent subarachnoid hemorrrhage after complete obliteration of cerebral aneurysms. Stroke 29: 2511–2513
Van den Berg WM Algra A van der Sprenkel 2003 Hypomagnesemia after aneurysmal subarachid hemorrhage. Neurosurgery 52 276–281
Van Gijn J, Wijdicks EFM (1998) Medical management of aneurysmal subarachnoid hemorrhage. In: Ginsberg MD, Bogousslavsky J: Vertebrovascular disease: Pathophysiology, diagnosis, management. Blackwell Science Vol II, S 1964–1978
Vajkoczy P, Meyer B, Weidauer S, Raabe A, Thome C, Ringel F, Breu V, Schmiedek P (2005) Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study. J Neurosurg 103:9–17.
Unterberg AW, Sakowitz OW, Sarrafzadeh AS, et al (2001) Role of bedside microdialysis in the diagnosis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 94:740–749.
Wiebers DO, Whisnant JP, Huston J, Meissner I, Brown RD, Piepgras DG, Forbes GS, Thielen K, Nichols D, peaco J, Jaeger L, Kassell NF, Torner JC (2003) Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 362: 103–110
Literatur
Anson JA, Spetzler RF (1992) Classification of spinal arteriovenous malformations and implications for treatment. BNI Quarterly 8: 2–8
Busse O, Hamer J, Paal G, Piotrowski W (1972) Spontane epidurale spinale Hämatome während und nach Anticoagulantienmedikation. Nervenarzt 6:318–322
Dam-Hieu P, Mineo JF, Bostan A, Nonent M, Besson G (2001) Concurrent spinal dural and intradural arteriovenous fistula. J Neurosurg 95 (Spine 1): 96–99
Fliedner E, Sartor K (1977) Über ein akutes spontanes spinales epidurales Hämatom. Fallbericht. Nervenarzt 48:603–607
Han PP, Theodore N, Porter RW, Detwiler PW, Lawton MT, Spetzler RF (1999) Subdural hematoma from a type I spinal arteriovenous malformation. J Neurosurg 90: 255–257
Jackson R (1869) Case of spinal apoplexy. Lancet 2:5–6
Kreppel D, Antoniadis G, Seeling W (2003) Spinal hematoma: a literature survey with meta-analysis of 613 patients. Neurosurg Rev 26: 1–49
Lawton TM, Porter RW, Heiserman JE, Jacobowitz R, Sonntag VKH, Dickman CA (1995) Surgical management of spinal epidural hematoma: relationship between surgical timing and neurological outcome. J Neurosurg 83:1–7
Mattle H, Sieb JP, Rohner M, Mumenthaler M (1987) Nontraumatic spinal epidural and subdural hematomas. Neurology 37:1351–1356
Mull (1996) Spinale Krankheiten — Krankheiten der Blutgefäße. In: Sartor K (Hrsg) Neuroradiologie. Thieme Stuttgart-New York, S 235–240
Oldenkott P, Preger R, Todorow S (1981) Spinale epidurale Hämatome und Antikoagulantienbehandlung. Med Welt 32: 46–49
Plagne R (1961) L’hématome extra-dural rachidien non traumatique (hématome épidural spontané). Thèse pour le Doctorat en Médecine (Diplôme d’Etat). Université de Clermont, Faculté mixte de Médecine et de Pharmacie
Rohde V, Küker W, Reinges MHT, Gilsbach JM (2000) Microsurgical treatment of spontaneous and non-spontaneous spinal epidural haematomas: neurological outcome in relation to aetiology. Acta Neurochir 142: 787–794
Tryba M (1993) Rückenmarksnahe Regionalanästhesie und niedermolekulare Heparine: pro. Anästhesiol Intensivmed Notfallmed Schmerzther 28:179–181
Vandermeulen EPE, Vermylen G, van Aken H (1993) Epidural and spinal anaesthesia in patients receiving anticoagulant therapy. Baillieres Clin Anaesthesiol 7:663–689
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Schwarz, S. et al. (2008). Blutungen. In: Schwab, S., Schellinger, P., Werner, C., Unterberg, A., Hacke, W. (eds) NeuroIntensiv. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68317-9_32
Download citation
DOI: https://doi.org/10.1007/978-3-540-68317-9_32
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-23051-9
Online ISBN: 978-3-540-68317-9
eBook Packages: Medicine (German Language)